Finally, we demonstrated that blocking leptin signaling by using the peptide LDFI significantly reduced mammosphere formation in metastatic breast cancer patient-derived cells, suggesting that strategies aimed at inhibiting leptin signaling represent a rationale therapeutic approach to target cancer stem cells. Here, LEP is linked to breast cancer.